You Searched For "mrna stock" and got 20 results
Sort By:
2 mins read
These are the 10 talked about stocks on Reddit's WallStreetBets
As traders look to replicate the success of WallStreetBets stocks, one data aggregator is compiling…
Matthew Fox
1 min read
Moderna extends 2-day gain to 32% after it says Omicron vaccine will be ready in early 2022
"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…
Matthew Fox
2 mins read
'From unreasonable to ridiculous': Here's why Moderna is set to fall 76%, according to Bank of America
"To justify $200 billion in value, one has to assume 1 to 1.5 billion doses of COVID-19 vaccine eac…
Matthew Fox
2 mins read
These are the top 10 stocks Reddit's Wall Street Bets is talking about right now
As traders look to replicate the success of Wall Street Bets stocks, one data aggregator is compili…
Matthew Fox
2 mins read
Moderna spikes 19% amid a flood of encouraging vaccine news, surpassing Merck in market value
Moderna, the almost 11 year old company that created a 95% effective pandemic ending vaccine in les…
Matthew Fox
1 min read
Moderna spikes 11% to record highs after it is selected to be added to S&P 500
Alexion Therapeutics, which is set to be acquired by AstraZeneca, will be replaced by Moderna in th…
Matthew Fox
1 min read
US stocks gain as jump in retail sales in June points to steady pace of economic recovery
US stocks gained on Friday after a day of market declines as investor concerns about rising inflati…
Matthew Fox
2 mins read
Dow slides 300 points to cap off first weekly decline in a month amid inflation worries
If inflation doesn't cool off soon, the Fed could be forced to change course sooner than it has bee…
Matthew Fox
2 mins read
Here are Insider's biggest healthcare stories for November
These are Insider's biggest healthcare stories for the month of November.
Leah Rosenbaum
1 min read
Moderna soars 6% as it begins vaccine testing in babies and children
Moderna and Johnson & Johnson's vaccines are approved for adults over 18, while the vaccine from Pf…
Isabelle Lee
2 mins read
Arcturus Therapeutics plummets 53% after analyst downgrades following COVID-19 vaccine trial updates
The Singapore Health Sciences Authority approved the Arcturus vaccine candidate for Phase 2 clinica…
Emily Graffeo
1 min read
Moderna slumps 11% as the vaccine-maker's Q1 revenue misses estimates
The pharma company's full-year sales forecast for its vaccine was raised to $19.2 billion, up from …
Shalini Nagarajan
2 mins read
The billionaire scientist who developed Pfizer's breakthrough vaccine has not sold any shares in partner BioNTech's surging stock
Sahin and his wife, Ozlem Tureci, are the "dream team" couple whose company partnered with Pfizer t…
Shalini Nagarajan
2 mins read
Novavax climbs 11% after announcing data from UK vaccine trial are expected in early 2021
The biotech firm initially fell in premarket trading as investors focused on a second delay to its …
Ben Winck
2 mins read
Moderna soars 16% after announcing plans to file for emergency use authorization as results indicate its COVID-19 vaccine is 94% effective
Moderna said the vaccine was more than 94% effective at preventing people in its late-stage trial f…
Shalini Nagarajan
2 mins read
AstraZeneca jumps 4% after CEO says its COVID-19 vaccine could reach 95% efficacy
AstraZeneca's vaccine could lead to a ramp-up of vaccinations, given that, unlike the other mRNA va…
Matthew Fox
2 mins read
22 biotech companies that will likely get bought as M&A heats up this summer
These are Insider's biggest healthcare stories for May 24.
Lydia Ramsey Pflanzer
2 mins read
Pfizer leaps 6% after releasing positive trial results for coronavirus vaccine
Pfizer is one of several firms racing to introduce the first effective coronavirus vaccine, with Mo…
Ben Winck
28 mins read
The CEO of Moderna on the moment he first realized the company could make a COVID-19 vaccine
In a recent Andreessen Horowitz podcast, Stéphane Bancel discusses how mRNA works and why it's tran…
Jorge Conde, Hanne Winarsky, …
1 min read
Bill Gates-backed CureVac jumps 18% on report it's in advanced talks with the EU for 225 million doses of its potential COVID-19 vaccine
The contract would also give the European Commission the option to purchase an additional 180 milli…